As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO Prostate Cancer, about managing side effects following prostate cancer treatment. While treatment ...

A less invasive therapy for prostate cancer is just as effective as surgery or radiotherapy but with a lower risk of side effects, a major study suggests. The treatment, named focal therapy, uses high ...

Radioligand therapy for prostate cancer is also called PSMA therapy because it targets prostate-specific membrane antigen (PSMA), a type of protein found in large amounts on the surface of up to 90 ...

A study by Leicester researchers shows that the timing of radiotherapy treatment may be as important as how it is given for ...

Men get told about the big two, which are incontinence and erectile dysfunction, usually in one sentence during a consultation where they were still processing the word cancer. The rest of the list ...

For many men with prostate cancer, weeks of daily treatments are no longer the norm. Jonathan Tward, MD, a radiation oncologist at Huntsman Cancer Institute, explains how image guidance, real-time ...

Two larger doses of radiotherapy for prostate cancer cause no additional side effects compared to the standard five doses of radiotherapy, according to results presented at the Congress of the ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have validated a test that can accurately predict which patients with prostate cancer are at higher risk of developing long-lasting ...

A national study of more than 20,000 men with prostate cancer compared long-term outcomes after radiation therapy or surgical removal of the prostate, with follow-up of up to 20 years. Men who ...

HHS unveiled a new Alzheimer's and dementia plan in Fort Lauderdale focused on prevention and early detection. Here is what is promised and proven. Final CDC Data Put U.S. Fertility Rate at Record Low ...

If you have advanced prostate cancer, your health care provider may have told you about a medicine called Truqap (capivasertib). In June 2026, the FDA approved Truqap for certain adults with prostate ...